In line with the implementation of Administrative Order (AO) No. 2008-0021 entitled “Gradual Phase-out of Mercury in all Philippine Health Care Facilities and Institutions” and AO No. 2020-0020 entitled “Guidelines on the Phase-out of Mercury Use in Dental Restorative Procedures”, the Food and Drug Administration is developing a policy entitled “Banning of all Mercury-Containing Thermometers, Sphygmomanometers, Liquid Mercury and Dental Amalgam Capsules”
In this regard, the FDA is inviting representatives from the medical device industry to attend the Virtual Public Hearing on the above-mentioned proposed FDA issuance on 28 June 2021 via Zoom. Eighty (80) slots have been allotted for those interested to attend the said activity. One (1) representative per company shall be accommodated.
To register and confirm your attendance, you may send an email to the Center for Device Regulation, Radiation Health, and Research – Product Research and Standards Development Division at [email protected]. Kindly send the following information when you register:
- Name and address of the company
- Name of participant
- Designation/Position of participant
- Email address of participant